Gene: RABEP2
Official Full Name: rabaptin, RAB GTPase binding effector protein 2provided by HGNC
Gene Summary: Predicted to enable GTPase activator activity and growth factor activity. Involved in regulation of cilium assembly. Located in cytosol; intracellular membrane-bounded organelle; and microtubule organizing center. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02735 | RABEP2 Knockout cell line (HeLa) | Human | RABEP2 | 1:3~1:6 | Negative | Online Inquiry |
KO02736 | RABEP2 Knockout cell line (HCT 116) | Human | RABEP2 | 1:2~1:4 | Negative | Online Inquiry |
KO02737 | RABEP2 Knockout cell line (HEK293) | Human | RABEP2 | 1:3~1:6 | Negative | Online Inquiry |
KO02738 | RABEP2 Knockout cell line (A549) | Human | RABEP2 | 1:3~1:4 | Negative | Online Inquiry |
RABEP2 Gene Knockout Cell Lines are specialized cell lines in which the RABEP2 gene has been deliberately disabled or "knocked out" using precise gene editing techniques, such as CRISPR/Cas9. This innovative tool allows researchers to study the role of RABEP2 in cellular processes like membrane trafficking, synaptic function, and cell signaling pathways, contributing significantly to our understanding of various physiological and pathological states.
The primary function of the RABEP2 gene involves mediating the vesicular trafficking of proteins within cells, which is crucial for maintaining cellular homeostasis and interaction with the extracellular environment. By using RABEP2 knockout cell lines, researchers can investigate the effects of RABEP2 deficiency on cellular functions and explore its implications in diseases where vesicular transport is compromised, such as neurodegenerative disorders.
This product holds great scientific importance, serving as a critical resource for both fundamental research and clinical applications. It enables scientists to elucidate the molecular mechanisms underlying various diseases and fosters the development of targeted therapies. The use of RABEP2 knockout cell lines can accelerate drug discovery processes by providing a platform for testing therapeutic interventions on altered cellular behavior associated with RABEP2 deficiencies.
One of the standout advantages of our RABEP2 Gene Knockout Cell Lines lies in their specificity and reliability compared to alternative models. Unlike transient transfection approaches or RNA interference, which may result in off-target effects, our knockout lines provide a stable and permanent solution that allows for consistent experimental outcomes. This precision increases the reproducibility and applicability of research findings, making it a valuable addition to any laboratory.
For researchers, clinicians, and biotech companies, RABEP2 Gene Knockout Cell Lines represent an indispensable asset. Their unique capabilities can lead to breakthroughs in understanding disease mechanisms and could facilitate the development of innovative therapies.
Our company is dedicated to providing high-quality biological products that empower scientists in their quest for knowledge and discovery. With extensive expertise in genetic engineering and a commitment to excellence, we offer reliable solutions to advance your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.